Pittman Scott M. 13D/13G Filings for Nuo Therapeutics, Inc. (AURX)

Pittman Scott M. 13D and 13G filings for Nuo Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-01-26
6:05 pm
Purchase
2026-01-2313DNuo Therapeutics, Inc.
AURX
Pittman Scott M.5,610,050
11.600%
208,996increase
(+3.87%)
Filing
2023-12-20
2:18 pm
Sale
2023-12-1813DNuo Therapeutics, Inc.
AURX
Pittman Scott M.5,401,054
12.100%
-519,301decrease
(-8.77%)
Filing
2022-07-05
08:01 am
Purchase
2020-10-0513DNuo Therapeutics, Inc.
AURX
Pittman Scott M.5,920,355
18.600%
5,920,355increase
(New Position)
Filing